发明名称 INHIBITION OF MAP4K4 THROUGH RNAI
摘要 RNAi constructs directed to MAP4K4 that demonstrate unexpectedly high gene silencing activities, and uses thereof are disclosed. The blunt-ended constructs have a double-stranded region of 19-49 nucleotides. The constructs have selective minimal modifications to confer an optimal balance of biological activity, toxicity, stability, and target gene specificity. For example, the strands may be modified (e.g., one or both ends of the sense strand is modified by 2′-O-methyl groups), such that the construct is not cleaved by Dicer or other RNAse III, the antisense strand may also be modified by a 2′-O-methyl group at the penultimate 5′-end nucleotide to greatly reduce off-target silencing.
申请公布号 US2012059046(A1) 申请公布日期 2012.03.08
申请号 US200913130194 申请日期 2009.11.19
申请人 WOOLF TOD M;KAMENS JOANNE;KHVOROVA ANASTASIA;SALOMON WILLIAM;RXI PHARMACEUTICALS CORPORATION 发明人 WOOLF TOD M;KAMENS JOANNE;KHVOROVA ANASTASIA;SALOMON WILLIAM
分类号 A61K31/7088;A61P3/00;A61P3/04;A61P3/06;A61P3/08;A61P3/10;A61P9/00;A61P9/12;A61P17/06;A61P27/02;A61P29/00;A61P31/14;A61P31/18;A61P35/00;A61P37/06;C12N5/071;C12N15/113 主分类号 A61K31/7088
代理机构 代理人
主权项
地址